用户测试（纽约证券交易所代码：UTE）交易量下跌6.3%

UserTesting Inc (NYSE:USER – Get Rating) shares traded down 6.3% on Wednesday . The company traded as low as $3.88 and last traded at $3.89. 10,458 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 424,115 shares. The stock had previously closed at $4.15.

Wall Street Analyst Weigh In

A number of equities analysts have commented on USER shares. Piper Sandler cut their price target on shares of UserTesting from $14.00 to $9.00 and set an "overweight" rating for the company in a research note on Monday, July 18th. Morgan Stanley cut their target price on shares of UserTesting from $11.00 to $9.00 and set an "overweight" rating for the company in a research report on Thursday, July 14th. Robert W. Baird lowered their price target on UserTesting to $8.00 in a research report on Tuesday, August 9th. Oppenheimer cut their price objective on UserTesting from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, June 17th. Finally, Raymond James decreased their price objective on UserTesting from $14.00 to $9.00 and set a "strong-buy" rating on the stock in a report on Friday, August 5th. Ten research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $11.40.

UserTesting Trading Down 1.3 %

The firm has a 50-day moving average of $5.08 and a 200-day moving average of $6.57.

UserTesting Company Profile

UserTesting, Inc engages in the operation of a software-as-a-service (SaaS) platform that enables organizations to know experiences of people as they engage with products, designs, apps, processes, concepts, or brands in the United States, the United Kingdom, and internationally. Its platform captures customer perspectives from targeted audiences who share their thoughts for digital, real-world, or omnichannel experiences.

See Also

• Get a free copy of the StockNews.com research report on UserTesting (USER)
• Is There a Cure for What is Ailing Teladoc Stock?
• No One Told These 3 Stocks It's a Down Week
• Why Medical Products Maker Repligen May Be A Potential Buy
• At 10%, Is Arbor Realty Trust Dividend Worth It?
• Investors Should Tune Into RF Industries

Receive News & Ratings for UserTesting Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UserTesting and related companies with MarketBeat.com's FREE daily email newsletter.